ESR1 and ductal breast carcinoma in situ: The most interesting aspect of 1q gain in breast cancer is its prevalence in almost all types of breast cancer like Estrogen Receptor (ER) positive, ER negative [12], Luminal A [13], Ductal carcinoma in situ (DCIS) and Invasive ductal carcinoma (IDC) [14].